Journal article
Assessing the effect of pneumococcal conjugate vaccines
Since 2000, more than 70 countries have introduced pneumococcal conjugate vaccines. Ecological studies—ie, studies that track disease trends over time in relation to the timing of interventions such as introduction of pneumococcal vaccines—have documented reductions in invasive pneumococcal disease, otitis media, and pneumococcal pneumonia after initiation of routine vaccination of infants with a seven-valent pneumococcal conjugate vaccine (PCV7) in the USA and elsewhere.
Languages
- English
Publication year
2011
Journal
The Lancet Infectious Diseases
Volume
10
Type
Journal article
Categories
- Service delivery
Diseases
- Pneumococcal disease
Countries
- United States of America
Tags
- Coverage monitoring
- New vaccine introduction
WHO Regions
- Region of the Americas
